Rita Jain - 15 Jun 2025 Form 4 Insider Report for ANAPTYSBIO, INC (ANAB)

Reporting relationship: Director
Issuer ticker: ANAB
Reported as of: 15 Jun 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 17 Jun 2025, 18:33:48 UTC
Prior SEC filing: 09 Jun 2025
Next SEC filing: 18 Jun 2025
Source filing: View source filing
Reporting owner signature: /s/ Eric Loumeau, Attorney-in-Fact

Key filing fact

Rita Jain filed Form 4 for ANAPTYSBIO, INC (ANAB) on 17 Jun 2025.

Key facts

This page summarizes Rita Jain's Form 4 filing for ANAPTYSBIO, INC (ANAB).
3 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 17 Jun 2025, 18:33.

Change

Previous filing in this sequence was filed on 09 Jun 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001707797 Primary reporting owner

Jain Rita

Relationship: Director
Address: C/O ANAPTYSBIO, INC., 10770 WATERIDGE CIRCLE, SUITE 210, SAN DIEGO
Signature: /s/ Eric Loumeau, Attorney-in-Fact
Signature date: 17 Jun 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ANAB transaction

Common Stock

Options Exercise

Transaction value: $0
Shares: +7,330
Change %: +162%
Price: $0.000000
Shares after: 11,864
Date: 15 Jun 2025
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ANAB transaction Derivative

Restricted Stock Unit

Options Exercise

Transaction value: $0
Shares: -1,300
Change %: -50%
Price: $0.000000
Shares after: 1,300
Date: 15 Jun 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 1,300
Exercise price
Footnotes: F1, F2

ANAB transaction Derivative

Restricted Stock Unit

Options Exercise

Transaction value: $0
Shares: -6,030
Change %: -100%
Price: $0.000000
Shares after: 0
Date: 15 Jun 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 6,030
Exercise price
Footnotes: F1, F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Each restricted stock award ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.

Footnote F2

The RSUs shall vest as to 1/3 of the total shares on June 15, 2024, and thereafter vests as to 1/3 of the total RSUs on June 15, 2025; and as to 1/3 of the total RSUs on June 15, 2026, subject to the provision of services to the Company on each vesting date.

Footnote F3

The RSUs vests as to 100% of the total RSUs on the date of the Issuer's 2025 annual meeting of shareholders, subject to the Reporting Person's provision of service to the Issuer on each vesting date.